|
|
 |
Welcome to Cardoz
Cardoz is a pharmaceutical company focused on developing novel drugs for inflammatory vascular conditions such as abdominal aortic aneurysm and atherosclerosis.
News
Press release - Stockholm October 5, 2011
Cardoz announces the successful completion of enrollment in the AORTA trial investigating CRD007 in patients with Abdominal Aortic Aneurysm
Click here to read the full press release
|
|
|
|